/GENX

GENX Stock - Genex Pharmaceutical, Inc.

Q: What is the analyst price target for GENX?

Analyst price target information is not currently available for GENX.

Q: What is GENX's market cap?

Market capitalization information is not currently available for GENX.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GENX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2004

FY2005

FY2006

FY2007

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.52

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2007	FY2006	FY2005	FY2004	FY2003
Revenue	$3.24M	$2.44M	$2.49M	$2.35M	$3,483
Gross Profit	$2.87M	$2.22M	$2.19M	$2.07M	$-301
Gross Margin	88.8%	91.1%	87.9%	88.0%	-8.6%
Operating Income	$466,137	$846,679	$920,586	$992,118	$52,255
Net Income	$342,549	$618,963	$625,014	$1.01M	$-52,255
Net Margin	10.6%	25.4%	25.1%	43.1%	-1500.3%
EPS	$0.02	$0.03	$0.04	$0.06	$-0.01

Company Overview

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.

Frequently Asked Questions about GENX

What is GENX's current stock price?

Genex Pharmaceutical, Inc. (GENX) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for GENX?

No analyst price targets are currently available for this stock.

What sector is Genex Pharmaceutical, Inc. in?

Genex Pharmaceutical, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is GENX's market cap?

Genex Pharmaceutical, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does GENX pay dividends?

No, Genex Pharmaceutical, Inc. does not currently pay a dividend to shareholders.